BIOPX vs. FCNTX
Compare and contrast key facts about Baron Opportunity Fund (BIOPX) and Fidelity Contrafund Fund (FCNTX).
BIOPX is managed by Baron Capital Group, Inc.. It was launched on Feb 29, 2000. FCNTX is managed by Fidelity. It was launched on May 17, 1967.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BIOPX or FCNTX.
Key characteristics
| BIOPX | FCNTX | |
|---|---|---|
| YTD Return | 36.45% | 36.45% |
| 1Y Return | 46.50% | 39.54% |
| 3Y Return (Ann) | -1.16% | 2.67% |
| 5Y Return (Ann) | 15.59% | 10.61% |
| 10Y Return (Ann) | 9.82% | 8.93% |
| Sharpe Ratio | 2.22 | 2.53 |
| Sortino Ratio | 2.85 | 3.42 |
| Omega Ratio | 1.40 | 1.47 |
| Calmar Ratio | 1.32 | 0.39 |
| Martin Ratio | 12.18 | 15.66 |
| Ulcer Index | 3.81% | 2.49% |
| Daily Std Dev | 20.86% | 15.44% |
| Max Drawdown | -67.79% | -99.93% |
| Current Drawdown | -4.90% | -99.29% |
Correlation
The correlation between BIOPX and FCNTX is 0.85, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
BIOPX vs. FCNTX - Performance Comparison
As of year-to-date, both investments have demonstrated similar returns, with BIOPX at 36.45% and FCNTX at 36.45%. Over the past 10 years, BIOPX has outperformed FCNTX with an annualized return of 9.82%, while FCNTX has yielded a comparatively lower 8.93% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BIOPX vs. FCNTX - Expense Ratio Comparison
BIOPX has a 1.31% expense ratio, which is higher than FCNTX's 0.39% expense ratio.
Risk-Adjusted Performance
BIOPX vs. FCNTX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Baron Opportunity Fund (BIOPX) and Fidelity Contrafund Fund (FCNTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BIOPX vs. FCNTX - Dividend Comparison
BIOPX has not paid dividends to shareholders, while FCNTX's dividend yield for the trailing twelve months is around 0.37%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIOPX Baron Opportunity Fund | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FCNTX Fidelity Contrafund Fund | 0.37% | 0.48% | 2.42% | 0.00% | 0.00% | 0.00% | 0.00% | 0.10% | 0.30% | 0.31% | 7.55% | 7.89% |
Drawdowns
BIOPX vs. FCNTX - Drawdown Comparison
The maximum BIOPX drawdown since its inception was -67.79%, smaller than the maximum FCNTX drawdown of -99.93%. Use the drawdown chart below to compare losses from any high point for BIOPX and FCNTX. For additional features, visit the drawdowns tool.
Volatility
BIOPX vs. FCNTX - Volatility Comparison
Baron Opportunity Fund (BIOPX) has a higher volatility of 5.78% compared to Fidelity Contrafund Fund (FCNTX) at 4.44%. This indicates that BIOPX's price experiences larger fluctuations and is considered to be riskier than FCNTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.